Homology Medicines Inc

NASDAQ:FIXX  
6.44
+0.09 (+1.42%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)372.26M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.51 Million
Adjusted EPS-$0.58
See more estimates
10-Day MA$6.51
50-Day MA$8.11
200-Day MA$10.56
See more pivots

Homology Medicines Inc Stock, NASDAQ:FIXX

One Patriots Park, Bedford, Massachusetts 01730
United States of America
Phone: +1.781.301.7277
Number of Employees: 205

Description

Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the design and development of treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing, and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.